Table: Shin Nippon Biomedical - 9-MTH group results

Shin Nippon Biomedical Laboratories

05/02/2025 24:00

Feb 5 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2024        Dec 31, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             22.24               17.98            32.00    
                 (+23.6 pct)         (+9.9 pct)       (+21.0 pct) 
  Operating          1.89                2.54             2.90    
                 (-25.3 pct)         (-33.0 pct)      (-30.3 pct) 
  Recurring          4.14                4.88             5.90    
                 (-15.3 pct)         (-29.0 pct)      (-15.9 pct) 
  Net                3.21                3.79             4.40    
                 (-15.5 pct)         (-12.8 pct)      (-20.5 pct) 
  EPS             76.99 yen           91.14 yen       105.68 yen  
  Ann Div                             50.00 yen        50.00 yen  
  -Q2 div         20.00 yen           20.00 yen                   
  -Q4 div                             30.00 yen        30.00 yen  
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T